Lymphoma Action Annual Report 2024

Lymphoma Action is the UK's only charity dedicated to lymphoma, the most common blood cancer. Their 2024 report demonstrates growing patient support, information services, and peer networks helping thousands of people navigate their diagnosis.

Report snapshot
16,000+ people supported Key Metric 1
£3.2m raised for services and research Key Metric 2
12,000 information packs distributed Key Metric 3
12 Views

📋About

Patient helpline, information resources, peer support groups, research funding, awareness campaigns

📊Key Metrics

16,000+ people supported Key Metric 1
£3.2m raised for services and research Key Metric 2
12,000 information packs distributed Key Metric 3

Key Outcomes

  • Patients feel better supported throughout treatment
  • Greater public recognition of lymphoma symptoms
  • Improved mental health outcomes for patients

📍Geography

UK-Wide

2025

Annual Report 2024/25

£20.8m raised in 2024/25 (up from £17.4m in 2023/24)
Key Metric 1
£9.6m raised from 176 legacy gifts; £14m committed to new Total Body PET-CT scanner
Key Metric 2
49,000 active supporters; 3,857 running participants (doubled in 3 years); 83p in every £1 goes directly to patients
Key Metric 3
MyChristie-MyHealth ePROMs system reduces clinician time on routine reviews by up to 23% and enables earlier symptom detection
2026

Impact Report Year Ending April 2026

2,829 children, parents, siblings and grandparents supported; 506 families with a child in treatment
Key Metric 1
220 bereaved families supported; 424 individuals on 93 boat trips; 692 individuals in 165 cabin breaks
Key Metric 2
£71,935 unlocked in essential support; 1,320 social work hours; 188 creative therapy sessions and 271 counselling sessions delivered
Key Metric 3
Families show average 0.7 point improvement across five Mo's Outcomes after support begins; biggest gains in social participation and accessing emotional support
2025

Closer to a Cure — 15 Years of Impact

£23.2m awarded to research since 2009; £18.2m directly to Centres of Excellence; Centres leveraged additional £23.2m — total £46.4m contribution to national investment
Key Metric 1
5 Centres of Excellence funded across UK; 39 PhD students supported; 260 research personnel supported; 167 publications underpinned
Key Metric 2
130+ research projects supported through Funded Initiatives; 23 novel therapies reviewed by BTR-NTA; BRAIN UK tissue bank holds 210,000+ cases and has supplied 26,000+ samples to 110+ studies
Key Metric 3
Blood test for high-grade brain tumours granted FDA Breakthrough Device Designation (2023); Barts Brain Tumour Centre grew from zero clinical trials in 2019 to running the most brain tumour clinical trials of any UK neuro-oncology centre in 2024